UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Rhythm Pharmaceuticals
RYTM
$7.96B
| $14.4M | ﹤0.01% |
227,627
+101,845
| +81% | +$6.24M |
|
1177
Kanzhun
BZ
$7.36B
| $14.3M | ﹤0.01% |
802,406
-8,750,516
| -92% | -$147M |
|
1178
Credit Acceptance
CACC
$6.08B
| $14.3M | ﹤0.01% |
28,053
+4,167
| +17% | +$2.05M |
|
1179
Host Hotels & Resorts
HST
$16B
| $14.2M | ﹤0.01% |
926,259
-6,627,687
| -88% | -$98.2M |
|
1180
Marathon Digital Holdings
MARA
$3.9B
| $14.2M | ﹤0.01% |
906,242
+262,931
| +41% | +$3.77M |
|
1181
SharkNinja
SN
$26.1B
| $14.2M | ﹤0.01% |
143,100
+92,287
| +182% | +$7.98M |
|
1182
Abercrombie & Fitch
ANF
$5B
| $14.2M | ﹤0.01% |
170,949
+43,560
| +34% | +$3.3M |
|
1183
Penske Automotive Group
PAG
$14.2B
| $14.2M | ﹤0.01% |
82,402
+13,518
| +20% | +$2.17M |
|
1184
ADT
ADT
$5.58B
| $14.1M | ﹤0.01% |
1,669,446
+515,196
| +45% | +$4.22M |
|
1185
Power Integrations
POWI
$3.61B
| $14.1M | ﹤0.01% |
252,673
+77,919
| +45% | +$4M |
|
1186
Calix
CALX
$2.39B
| $14.1M | ﹤0.01% |
265,263
+88,935
| +50% | +$3.8M |
|
|
GMS
1187
DELISTED
GMS Inc
GMS
| $14.1M | ﹤0.01% |
129,515
+22,051
| +21% | +$1.71M |
|
1188
Workiva
WK
$3.54B
| $14.1M | ﹤0.01% |
205,262
+28,382
| +16% | +$1.95M |
|
|
ESGR
1189
DELISTED
Enstar Group
ESGR
| $14M | ﹤0.01% |
41,737
+2,549
| +7% | +$853K |
|
1190
ACM Research
ACMR
$5.79B
| $14M | ﹤0.01% |
541,737
-174,823
| -24% | -$3.93M |
|
1191
Axsome Therapeutics
AXSM
$10.9B
| $14M | ﹤0.01% |
134,101
+59,209
| +79% | +$6.27M |
|
1192
Cactus
WHD
$5.44B
| $14M | ﹤0.01% |
320,164
+93,233
| +41% | +$3.89M |
|
1193
Clearway Energy Class C
CWEN
$6.7B
| $13.9M | ﹤0.01% |
435,391
+17,220
| +4% | +$514K |
|
1194
Insight Enterprises
NSIT
$4.38B
| $13.9M | ﹤0.01% |
100,703
+26,444
| +36% | +$3.56M |
|
1195
Freshpet
FRPT
$3.22B
| $13.9M | ﹤0.01% |
204,485
+49,567
| +32% | +$3.87M |
|
1196
Urban Outfitters
URBN
$6.59B
| $13.8M | ﹤0.01% |
190,243
+47,575
| +33% | +$2.86M |
|
1197
Cytokinetics
CYTK
$10.4B
| $13.8M | ﹤0.01% |
416,253
+107,357
| +35% | +$3.73M |
|
1198
Hecla Mining
HL
$11.3B
| $13.7M | ﹤0.01% |
2,291,281
+332,005
| +17% | +$1.83M |
|
1199
Cal-Maine
CALM
$3.99B
| $13.7M | ﹤0.01% |
137,322
+51,900
| +61% | +$4.96M |
|
1200
UL Solutions
ULS
$15.8B
| $13.7M | ﹤0.01% |
187,698
+63,927
| +52% | +$4.19M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.